Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

DNA Microarrays

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Breast cancer (Tokyo, Japan)·2026

Same author

Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.

Breast cancer (Tokyo, Japan)·2026

Same author

Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2- metastatic breast cancer: a multicenter prospective cohort study.

Breast cancer research : BCR·2026

Same author

Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness).

Breast cancer (Tokyo, Japan)·2026

Same author

Final overall survival analysis of the APPLE study: atezolizumab and platinum-pemetrexed with or without bevacizumab for metastatic nonsquamous non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2026

Same author

Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.

Breast cancer (Tokyo, Japan)·2026

Search research articles

Related Experiment Video

Updated: May 11, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer.

Issei Kurahashi¹, Yoshihiko Fujita, Tokuzo Arao

¹Department of Planning, Information, and Management, University of Tokyo, Tokyo, Japan.

|May 15, 2013

Summary

Researchers identified potential diagnostic biomarkers for cancer of unknown primary (CUP) by analyzing gene expression profiles. This study highlights specific ribosomal protein genes and pathways involved in metastasis and apoptosis, offering new insights into CUP's molecular basis.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Experiment Videos

Last Updated: May 11, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Area of Science:

Molecular biology
Oncology
Genomics

Background:

The molecular basis of cancer of unknown primary (CUP) is poorly understood.
The existence of a common biological entity in CUP is uncertain.
This study investigates potential common diagnostic biomarkers for CUP.

Purpose of the Study:

To identify a common diagnostic biomarker for cancer of unknown primary (CUP).
To analyze gene expression profiles in CUP tumors.
To explore the molecular characteristics of CUP.

Main Methods:

Microarray gene expression analysis of tumor mRNA from 60 CUP patients.
Normalization using asinh transformation to create CUP-specific gene expression profiles.
Comparison with non-CUP groups using t-tests to identify significant genes (p<0.001).

Main Results:

Identified 44 up-regulated genes in CUP, including 6 ribosomal protein genes.
Two ribosomal protein genes (RPS7 and RPL11) are linked to the Mdm2-p53 pathway.
Genes associated with metastasis and apoptosis were also identified, suggesting biological attributes of CUP.

Conclusions:

The identified up-regulated and down-regulated genes may serve as unique biomarkers for CUP.
Protein products of these genes could have clinical utility in diagnosing CUP.
This research provides a foundation for further investigation into CUP's molecular underpinnings.